Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
KLTO	KLOTHO NEUROSCIENCES INC	$7.05M	-1,779.90%	-275.00%	-1,046.94%	-2,476.20%	3.68	0.29	N/A	N/A	N/A
LPTX	LEAP THERAPEUTICS INC	$15.75M	-162.70%	-120.50%	-329.07%	508.90%	0.67	2.41	N/A	N/A	N/A
OVID	OVID THERAPEUTICS INC	$20.62M	-34.10%	-25.30%	-34.52%	-32.10%	0.38	4.93	100.00%	-4,557.10%	-4,557.12%
LPCN	LIPOCINE INC	$19.48M	-26.70%	-24.80%	-27.97%	-34.80%	0.07	15.64	100.00%	-146.10%	-146.11%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$3.52M	-237.50%	-189.30%	-285.68%	1,253.10%	0.31	4.26	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$110.98M	-22.20%	-15.30%	-16.43%	5,088.20%	0.43	3.82	97.20%	-169.60%	-169.57%
TNYA	TENAYA THERAPEUTICS INC	$77.43M	-92.20%	-74.50%	-81.48%	-96.90%	0.21	6.68	N/A	N/A	N/A
TOVX	THERIVA BIOLOGICS INC	$3.57M	-116.60%	-66.20%	-103.33%	-138.60%	1.08	1.53	N/A	N/A	N/A
PHGE	BIOMX INC	$14.29M	-149.90%	-78.60%	-103.96%	-125.30%	0.86	3.35	N/A	N/A	N/A
TTNP	TITAN PHARMACEUTICALS INC	$3.98M	-145.90%	-129.20%	-224.29%	2,322.80%	0.15	7.73	N/A	N/A	N/A
KZR	KEZAR LIFE SCIENCES INC	$30.03M	-62.30%	-51.20%	-71.19%	-66.80%	0.22	7.09	N/A	N/A	N/A
NBTX	NANOBIOTIX SA	$181.64M	N/A	-84.50%	-713.70%	-418.40%	-2.03	1.04	100.00%	947.50%	841.93%
KRON	KRONOS BIO INC	$41.15M	-64.20%	-47.20%	-64.32%	-97.70%	0.36	12.93	100.00%	-701.50%	-701.53%
KPRX	KIORA PHARMACEUTICALS INC	$9.49M	-42.80%	-32.20%	-34.24%	-46.30%	0.44	5.14	100.00%	-60,257.30%	-49,209.99%
JUNS	JUPITER NEUROSCIENCES INC	$18.54M	N/A	-117.10%	-102.14%	257.30%	0.62	1.91	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$17.21M	-107.00%	-100.50%	-136.88%	-1,258.20%	0.27	4.24	99.50%	-1,784.20%	-1,784.18%
GDTC	CYTOMED THERAPEUTICS LTD	$23.22M	-24.90%	-22.40%	-26.39%	-62.80%	0.11	9.89	75.40%	-3,621.10%	-3,591.88%
IVA	INVENTIVA SA	$315.59M	N/A	-195.40%	5,384.47%	-342.30%	-2.12	0.92	100.00%	-1,251.00%	-645.04%
KAPA	KAIROS PHARMA LTD	$9.94M	-112.60%	-71.80%	-49.33%	-290.40%	0.11	7.52	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$177.72M	-162.90%	-33.50%	-58.27%	-58.30%	11.57	2.60	100.00%	-245.90%	-226.11%
VALN	VALNEVA SE	$520.48M	-43.40%	-16.40%	-14.69%	-13.40%	1.75	2.70	46.60%	-43.20%	-29.69%
IOBT	IO BIOTECH INC	$67.86M	-162.60%	-125.10%	-354.39%	1,698.90%	0.73	2.32	N/A	N/A	N/A
INZY	INOZYME PHARMA INC	$255.02M	-160.00%	-82.50%	-192.96%	-79.90%	1.99	2.19	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$28.75M	N/A	-140.70%	124.01%	292.10%	-1.20	0.30	N/A	N/A	N/A
INDP	INDAPTUS THERAPEUTICS INC	$6.33M	-333.00%	-216.40%	-562.47%	1,251.80%	0.93	1.90	N/A	N/A	N/A
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	N/A	N/A	N/A	13.78%	N/A	0.59	1.37	61.40%	14.90%	22.77%
INAB	IN8BIO INC	$11.80M	-217.00%	-138.40%	-162.16%	-227.20%	0.43	4.30	N/A	N/A	N/A
IMRN	IMMURON LTD	$9.18M	-52.80%	-45.90%	-70.35%	-285.20%	0.18	6.80	78.60%	-73.90%	-73.82%
IKNA	IKENA ONCOLOGY INC	$54.53M	-32.00%	-28.80%	-34.05%	-40.80%	0.11	13.31	N/A	N/A	N/A
IGC	IGC PHARMA INC	$25.74M	-122.20%	-88.20%	-137.19%	-207.40%	0.45	1.15	51.50%	-712.70%	-712.70%
CLDI	CALIDI BIOTHERAPEUTICS INC	$14.18M	N/A	-203.90%	-198.58%	-815.00%	1.12	2.12	N/A	N/A	N/A
HOOK	HOOKIPA PHARMA INC	$21.27M	-120.60%	-77.50%	-164.55%	-402.20%	0.80	3.61	100.00%	-784.00%	-785.15%
RADX	RADIOPHARM THERANOSTICS LTD	$28.23M	-105.50%	-52.50%	-50.53%	-174.90%	0.76	3.37	4.00%	-2,427.10%	-2,381.21%
GRCE	GRACE THERAPEUTICS INC	$30.08M	-23.30%	-19.80%	-28.56%	1,350.90%	0.17	6.06	N/A	N/A	N/A
SNTI	SENTI BIOSCIENCES INC	$83.46M	-177.20%	-67.40%	-76.04%	-73.70%	1.19	4.22	N/A	N/A	N/A
GNTA	GENENTA SCIENCE SPA	$81.39M	-54.10%	-48.00%	-70.04%	-71.10%	0.19	6.89	N/A	N/A	N/A
GLYC	GLYCOMIMETICS INC	$16.91M	-293.90%	-206.20%	-873.60%	966.20%	0.78	2.29	N/A	N/A	N/A
SLRX	SALARIUS PHARMACEUTICALS INC	$1.67M	-324.10%	-174.40%	-9,003.36%	684.80%	36.81	1.01	N/A	N/A	N/A
GLTO	GALECTO INC	$4.05M	-99.90%	-89.00%	-133.57%	-1,286.10%	0.12	9.62	N/A	N/A	N/A
REVB	REVELATION BIOSCIENCES INC	$2.42M	-505.40%	-194.70%	-500.15%	330.90%	0.38	3.61	N/A	N/A	N/A
CSCI	COSCIENS BIOPHARMA INC	$10.96M	-101.00%	-43.90%	-70.30%	-129.20%	2.07	2.88	47.30%	-194.50%	-187.49%
GNFT	GENFIT SA	$215.98M	2.20%	0.90%	8.68%	15.10%	1.19	1.23	100.00%	2.10%	9.33%
NBY	NOVABAY PHARMACEUTICALS INC	$3.43M	163.60%	50.40%	53.80%	279.60%	0.60	2.95	65.60%	37.10%	51.20%
MBIO	MUSTANG BIO INC	$5.43M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
ENLV	ENLIVEX THERAPEUTICS LTD	$23.41M	-56.90%	-49.90%	-66.51%	-634.60%	0.17	6.84	N/A	N/A	N/A
TNFA	TNF PHARMACEUTICALS INC	$2.54M	-204.70%	-79.90%	-106.08%	-263.30%	0.57	1.37	N/A	N/A	N/A
PLUR	PLURI INC	$38.17M	N/A	-57.80%	N/A	-44.70%	N/A	N/A	52.10%	-2,003.30%	-2,082.79%
SNPX	SYNAPTOGENIX INC	$3.18M	-121.70%	-61.50%	-80.54%	1,303.90%	1.72	72.71	N/A	N/A	N/A
ATHE	ALTERITY THERAPEUTICS LTD	$44.69M	-155.80%	-120.90%	-252.18%	-452.10%	0.36	3.84	100.00%	-531.30%	-530.10%
SWTX	SPRINGWORKS THERAPEUTICS INC	$3.49B	-51.10%	-43.80%	-59.78%	-58.10%	0.21	4.33	93.20%	-115.60%	-115.14%
SNSE	SENSEI BIOTHERAPEUTICS INC	$7.81M	-69.00%	-59.00%	-87.62%	-82.00%	0.20	6.82	N/A	N/A	N/A
STTK	SHATTUCK LABS INC	$49.34M	-79.70%	-69.10%	-101.08%	-185.10%	0.14	9.08	100.00%	-1,533.00%	-1,532.96%
IPA	IMMUNOPRECISE ANTIBODIES LTD	$16.10M	-148.10%	-82.10%	-139.08%	-174.50%	0.81	2.32	50.80%	-192.20%	-212.12%
SPRC	SCISPARC LTD	$3.48M	79.70%	58.40%	74.02%	127.40%	0.17	5.36	38.70%	481.20%	507.12%
LSB	LAKESHORE BIOPHARMA CO LTD	$219.43M	-41.10%	-15.70%	-31.61%	-21.60%	1.38	1.17	80.60%	-35.50%	-33.03%
LIPO	LIPELLA PHARMACEUTICALS INC	$13.76M	-224.00%	-172.80%	-125.78%	-4,587.70%	0.19	6.21	100.00%	-987.00%	-986.98%
JBIO	JADE BIOSCIENCES INC	$6.39M	-60.00%	-54.30%	-65.11%	-103.60%	0.03	32.01	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #1 top biotech stock out of 657 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 11 points higher than the biotech industry average of 24.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 17.65% over the past year, overperforming other biotech stocks by 97 percentage points.

Ptc Therapeutics has an average 1 year price target of $61.85, an upside of 31.03% from Ptc Therapeutics's current stock price of $47.20.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 46.15% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 15.38% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 657 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 58, which is 34 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 43.6% over the past year, overperforming other biotech stocks by 123 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the #3 top biotech stock out of 657 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Incyte (NASDAQ:INCY) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: C, Financials: B, and AI: B.

Incyte (NASDAQ:INCY) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

INCY passed 15 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 14.18% over the past year, overperforming other biotech stocks by 93 percentage points.

Incyte has an average 1 year price target of $73.50, an upside of 12.56% from Incyte's current stock price of $65.30.

Incyte stock has a consensus Hold recommendation according to Wall Street analysts. Of the 10 analysts covering Incyte, 10% have issued a Strong Buy rating, 0% have issued a Buy, 90% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Jade Biosciences (NASDAQ:JBIO)

Jade Biosciences (NASDAQ:JBIO) has an annual dividend yield of 31.11%, which is 25 percentage points higher than the biotech industry average of 6.04%.

Jade Biosciences's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.08%, which is the same as the biotech industry average of 6.04%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.36%, which is -4 percentage points lower than the biotech industry average of 6.04%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.58% in the last day, and up 5.12% over the last week. Neuraxis was the among the top gainers in the biotechnology industry, gaining 75.77% yesterday.

Neuraxis shares are trading lower. The company announced a direct offering consisting of 1.5 million shares.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -16.93% in the past year. It has overperformed other stocks in the biotech industry by 62 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 19.85% in the past year. It has overperformed other stocks in the biotech industry by 99 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 2.21% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

55.18% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 103.48% over the next year.

2.66% of biotech stocks have a Zen Rating of A (Strong Buy), 3.99% of biotech stocks are rated B (Buy), 38.36% are rated C (Hold), 34.37% are rated D (Sell), and 20.62% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -156.07x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Ptc Therapeutics (NASDAQ:PTCT)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Incyte (NASDAQ:INCY)

1. Jade Biosciences (NASDAQ:JBIO)

2. Dominari Holdings (NASDAQ:DOMH)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Ptc Therapeutics (NASDAQ:PTCT)

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

3. Incyte (NASDAQ:INCY)

1. Jade Biosciences (NASDAQ:JBIO)

2. Dominari Holdings (NASDAQ:DOMH)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.